Sign in
4

Changes in Ownership

TransMedics Group, Inc. Filed Acc 0000950170-25-004192

Chief Commercial Officer sold 1,083 shares at $80.05 ($86,694)

  • Chief Commercial Officer acquired 1,083 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Khayal Tamer I · Chief Commercial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-07 Exercise or conversion : show line 1 in the form 10b5-1 +1,083 $13.28 $14,382 21,926 D
2025-01-07 Sale : show line 2 in the form 10b5-1 −1,083 $80.05 $86,694 20,843 D
Open-market sales · 1,083 sh · avg $80.05 · $86,694

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-07 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −1,083 15,167 D
Loading xslF345X05/ownership.xml…